足月胎膜早破临床干预的效果分析  被引量:1

The efficacy of clinical intervention on term premature rupture of membrane

在线阅读下载全文

作  者:何芳[1] 高佳星[1] HE Fang;GAO Jia-xing(Department of Obstetrics and Gynecology,Mianyang People's Hospital,Mianyang 621000,China.)

机构地区:[1]绵阳市人民医院妇产科,四川绵阳621000

出  处:《中国处方药》2018年第8期10-12,共3页Journal of China Prescription Drug

摘  要:目的探讨足月胎膜早破产妇行缩宫素干预的临床效果。方法回顾性分析579例足月产妇的临床资料,依自然临产和引产时间分为12 h内自然临产者(A组),12~24 h自然临产者(B组),12 h未临产行缩宫素引产(C组),24 h未临产行缩宫素引产(D组),比较各组产妇分娩方式,产后并发症和围产儿病率。结果 D组产妇剖宫产率(χ2=22.881,P<0.001)、宫内感染率(χ2=36.389,P<0.001)和产褥病率(χ2=33.644,P<0.001)均明显高于其它组;D组产妇出生婴儿1 min Apgar评分<7分例数(χ2=8.537,P=0.003),围产儿病率(χ2=10.463,P=0.001)显著高于A组。结论足月产妇中24 h未临产行缩宫素引产将显著增加母婴并发症发生风险,早期干预将减少剖宫产率和并发症的发生。Objective To observe the clinical effect of oxytocin intervention for puerpera with full-term premature rupture of membranes.Methods The clinical data of 579 cases with full-term premature rupture were collected by retrospective analysis.Based on natural labor and at different times of odinopoeia,the puerpera were divided into four groups:the natural labor within 12 h(A group),the natural labor within 12~24 h(B group),administered for oxytocin induction for women not in labor at 12 h after PROM(C group),administered for oxytocin induction for women not in labor at 24 h after PROM(D group),the delivery mode,postpartum complications and the incidence of perinatal disease were compared.Results The cesarean section rate of group D(χ2=22.881,P<0.001),the incidence of intrauterine infection(χ2=36.389,P<0.001)and puerperal morbidity(χ2=33.644,P<0.001)were significantly higher than other groups;the babies with 1 min Apgar score<7,who come from mothers of group D(χ2=8.537,P=0.003),perinatal morbidity was significantly higher than group A(χ2=10.463,P=0.001).Conclusion The puerpera administered for oxytocin induction for women not in labor at 24 h after PROM have significantly high risk of complications in maternal and child,the early intervention will reduce the cesarean section rate and complications.

关 键 词:足月胎膜早破 缩宫素引产 并发症 

分 类 号:R714.433[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象